Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis

Skin Research and Technology

Volumn 15, Issue 2, 2009, Pages 187-194

  Nair, Anroop ^a,c   Reddy, Chandrasekhar ^a   Jacob, Shery ^b  

^a PES COLLEGE OF PHARMACY   (India)

^b MANIPAL UNIVERSITY   (India)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Atenolol; Chemical enhancers; Iontophoresis; Transdermal

Indexed keywords

ADVERSE EFFECTS; ATENOLOL; BINARY SYSTEMS; CHEMICAL ENHANCERS; COMBINED EFFECTS; DRUG CONCENTRATIONS; EFFECTIVE CONCENTRATIONS; FORMAMIDE; IN-VITRO; IONTOPHORESIS; N-METHYL-2-PYRROLIDONE; PATIENT COMPLIANCES; PERMEATION ENHANCERS; POLYETHYLENE GLYCOL 400; SIDE EFFECTS; SKIN CONTACTS; SULPHATE; TRANSDERMAL; TRANSDERMAL DELIVERIES; WATER ETHANOLS;

ACIDS; AGENTS; AMIDES; CONCENTRATION (PROCESS); DRUG DELIVERY; DRUG PRODUCTS; ELECTROTHERAPEUTICS; ETHANOL; ETHYLENE GLYCOL; IONIC LIQUIDS; OLEIC ACID; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SKIN; SODIUM; SYSTEMS (METALLURGICAL);

ELECTROPHORESIS;

1 METHYL 2 PYRROLIDINONE; ATENOLOL; DODECYL SULFATE SODIUM; MACROGOL 400; MENTHOL; N,N DIMETHYLFORMAMIDE; OLEIC ACID;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; ION CURRENT; ION TRANSPORT; IONTOPHORESIS; MEDICAL RESEARCH; NONHUMAN; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; IONTOPHORESIS; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; SWINE;

EID: 65249090258     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2009.00350.x     Document Type: Article

References (46)

1. Bryan W. β-blockers and the treatment of hypertension. J Hypertens 2007; 25: 1351-1353.
2. Thomas NS, Panchagnula R. Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action. Eur J Pharm Sci 2003; 18: 71-79.
3. Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991; 96: 495-499.
4. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999; 184: 1-6.
5. Mitragotri S. Synergestic effect of enhancers for transdermal drug delivery. Pharm Res 2003; 17: 1354-1359.
6. Wang Y, Thakur R, Fan Q, Michnaik B. Transdermal iontophoresis: Combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm 2005; 60: 179-191.
7. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoresis drug delivery. Adv Drug Delivery Rev 2004; 56: 619-658.
8. Meidan VM, Khalil MA, Michniak BB. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers. Int J Pharm 2003; 264: 73-83.
9. Barry BW. Drug delivery routes in skin: A novel approach. Adv Drug Delivery Rev 2002; 54: S31-S40.
10. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis: Electroepulsion and electroosmosis. J Control Release 2000; 64: 129-132.
11. Naik A, Kalia YN, Guy RH. Transdermal drug delivery: Overcoming the skins barrier function. Pharm Sci Tech Today 2000; 3: 318-326.
12. Kanikkannan N, Kandimalla K, Lamba SS, Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 1999; 6: 593-608.
13. Williams AC, Barry BW. Skin absorption enhancers. Crit Rev Therap Drug Carrier Syst 1992; 9: 305-353.
14. Bhatia KS, Gao S, Freeman TP, Singh J. Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. J Pharm Sci 1997; 86: 1011-1014.
15. Sinha VR, Kaur MP. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 2000; 26: 1131-1140.
16. Jain GK, Kaul JL, Agrawal SS. In vitro transdermal delivery of atenolol using mouse and guinea pig. Indian J Exp Biol 1993; 31: 691-693.
17. Modamio P, Lastra CF, Marino EL. A comparative in vitro study of percutaneous preparations of β-blockers in human skin. Int J Pharm 2000; 194: 249-259.
18. Mahjour M, Mauser BE, Rashidbaigi ZA, Fawzi MB. Effects of propylene glycol diesters of caprylic and capric acids (Miglyol 840) and ethanol binary systems on in vitro skin permeation of drugs. Int J Pharm 1993; 95: 161-169.
19. Reddy LH, Ghosh B. Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin. Indian J Exp Biol 2001; 39: 47-51.
20. Denet AR, Ucakar B, Preat V. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: A mechanistic approach. Pharm Res 2003; 20: 1946-1951.
21. Anroop B, Ghosh B, Parcha V, Kumar A, Khanam J. Synthesis and comparative skin permeability of atenolol and propranolol esters. J Drug Delivery Sci Tech 2005; 15: 187-190.
22. Shin SC, Choi JS. Enhanced bioavailability of atenolol by transdermal administration of the ethylene vinyl acetate matrix in rabbits. Eur J Pharm Biopharm 2003; 56: 439-443.
23. Gupta SP, Jain SK. Development of matrix membrane transdermal drug delivery system for atenolol. Drug Delivery 2004; 11: 281-286.
24. Cho CW, Shin SC. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Int J Pharm 2004; 287: 67-71.
25. Banga AK. Electrically assisted transdermal and topical drug delivery. Bristol: Taylor and Francis, 1998: 33-35.
26. Cullander C. What are the pathways of iontophoresis current flow through mammalian skin. Adv Drug Delivery Rev 1992; 9: 119-135.
27. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001; 52: 103-112.
28. Slough CL, Spinelli MJ, Kasting GB. Transdermal delivery of etidronate in the pig via iontophoresis. J Memb Sci 1998; 35: 161-165.
29. Sasaki H, Igarashi Y, Nagano T, Nishida K, Nakamura J. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. Pharm Res 1995; 12: 1146-1150.
30. Hardman JG, Limbird LE. Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. New York: McGraw-Hill, 1996: 1924-2023.
31. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. Transdermal delivery of nalaxone: Effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 2001; 219: 95-105.
32. Bommannan D, Potts RO, Guy RH. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release 1991; 16: 299-304.
33. Rowe ES. Lipid chain length and temperature-dependence of ethanol phosphatidyl choline interactions. Biochemistry 1983; 22: 3299-3305.
34. Femenia-Font A, Balaguer-Fernandez C, Merino V, Rodilla V, Lopez-Castellano A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptin succinate. Eur J Pharm Biopharm 2005; 61: 50-55.
35. Higaki K, Amnuaikit C, Kimura T. Strategies for overcoming the stratum corneum: Chemical and physical approaches. Am J Drug Delivery 2003; 1: 187-214.
36. Kobayashi D, Matsuzawa T, Sugibayashi K, Morimoto Y, Kobayashi M, Kimura M. Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin. Biol Pharm Bull 1993; 16: 254-258.
37. Williams AC, Barry BW. Penetration enhancers. Adv Drug Delivery Rev 2004; 56: 603-618.
38. Kim DD, Kim JL, Chien YW. Mutual hairless rat skin permeation enhancing effect of ethanol/water system. J Pharm Sci 1996; 85: 1191-1195.
39. Borras-Bolasco J, Diez-Sales O, Lopez A, Herraez-Dominguez M. A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate. Int J Pharm 2004; 269: 121-129.
40. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci 1995; 84: 312-317.
41. Godwin DA, Michniak BB, Player MP, Sowell JW. Transdermal and dermal enhancing activity of pyrrolidones in hairless mouse skin. Int J Pharm 1997; 155: 241-250.
42. Lee PJ, Langer R, Shastri VP. Role of n -methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci 2005; 94: 912-917.
43. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release 1987; 6: 85-97.
44. Bhatia KS, Singh J. Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultra structure of human epidermis. Int J Pharm 1999; 180: 235-250.
45. Cornwell PA, Barry BW. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int J Pharm 1993; 94: 189-194.
46. Smyth HDC, Becket G, Mehta S. Effect of permeation enhancer pretreatment on the iontophoresis of luteinizing hormone releasing hormone through human epidermal membrane. J Pharm Sci 2002; 91: 1296-1307.